Yta4 decreases the affinity of Dnm1 for GTP. by Jiajia He (795335)

Absence of adaptive immunity decreases tumor cell damage in MDR1A deficiency. by Eva Maria Hennenberg (4234018)

Overexpression of FTH1P3 decreased the miR-224-5p expression. by Xiaoli Zheng (232806)

“…<p>(A) Elevated expression of FTH1P3 decreased the miR-224-5p expression in the MUM-2B cell. …”

Cancer drugs that decrease cardiomyocyte viability induce cellular stress. by E. Renee Matthews (18071587)

rVλ6Wil fibrils cause a decrease in cardiomyocytes MTT reduction without inducing cell death. by Helen P. McWilliams-Koeppen (116503)

“…(C) Cell number, quantified using crystal violet (black) did not decrease over 72 h of incubation with 1 μM rVλ6Wil fibrils despite a decrease in MMT reduction (grey; n = 3 samples per time point). …”

The <i>P[syt^P-L]</i> mutation decreases the Ca²⁺ affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

“…Left, representative traces of responses stimulated with a 20 ms interpulse interval. Scale bar 5 mV, 40 ms. …”

Tax expression is associated with decreased cellular motility. by Saumya Ramanayake (7879091)

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…After 4 weeks, when the tumor size was approximately 100 mm³ (T₀) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”

Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”

Growth, ammonium metabolism, and photosynthetic properties of <i>Ulva australis</i> (Chlorophyta) under decreasing pH and ammonium enrichment - Fig 5 by Leah B. Reidenbach (4620856)

“…<p><b>(A) Light saturation point (E</b>_<b>k</b><b>), (B) initial slope of the curve (</b>α<b>), and (C) slope of photoinhibition at high photon flux densities (</b>β<b>) from rapid light curves for <i>Ulva australis</i> grown under ambient and enriched NH</b>_<b>4</b>^<b>+</b> <b>treatments across a range of pH</b>_<b>T</b>. …”

Automated wound healing assay showing decreased motility of IL-4 treated HCAEC. by Tom Skaria (2733439)

Deletion of TAL does not decrease GNG flux. by Julie Kovářová (4114573)

Decreased HbNO production in HbE/ß-thal subjects. by Attaphon Chamchoi (5774669)

BCG-AS−Ndk has decreased intracellular survival due to increased phagolysosome fusion. by Jim Sun (367834)

eIF5a is up-regulated in unruptured AAAs and decreased in ruptured AAAs. by Dong Ma (584680)

Subjects:

Spatial training decreases the association between Ndfip1 and Nedd4 and decreases endogenous Beclin 1 ubiquitination in the hippocampus. by Wei-Lun Hsu (1756123)

“…Endogenous Beclin 1 ubiquitination level is decreased in Nedd4 siRNA-transfected rats (t_1,6 = 5.78, <i>p</i> = 0.001). …”

Decreased respiratory performance of children and adolescents with myelomeningocele who use a wheelchair – preliminary data by E.J. Martins (7141313)

Targeted point mutation (F639A) in the GluN1 subunit decreases ethanol sensitivity of NMDA receptors. by Carolina R. den Hartog (484817)

Resveratrol decreased tumor latency in <i>Sirt1^Y/+</i> mice. by Katherine V. Clark-Knowles (368164)

Transient ATX overexpression decreases vessel branching but does not delay retinal vascularization. by Hiroshi Yukiura (741223)